ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

DeVita On Problems Of Drug Response: There May be Tw Populations Of Cells; Molecular Medicine will Change Treatment

December 13, 1991

Patients Prefer Silicone Over Saline Implants

November 26, 2010

In Brief: Steve Carter Accepts Job With Bristol, Phillips Elected NCG Chairman; Murray Copeland Dies

April 9, 1982

ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients

April 27, 2012

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997